福安藥業(300194.SZ):擬在美國設立二級子公司 推進與Red Realty LLC股權購買和增資協議的實施
格隆匯11月15日丨福安藥業(300194.SZ)公佈,公司原計劃在香港特別行政區設立二級子公司,用以推進與Red Realty LLC在CBD產業的合作,但基於近期市場環境變化等因素,公司對原計劃進行調整,改在美國設立二級子公司,終止設立香港子公司。
為推進上述《股權購買和增資協議》的實施,同時進一步開拓國際業務,公司擬通過向子公司福安藥業集團寧波天衡製藥有限公司(“天衡藥業”)增資2.4億元,同時天衡藥業以自有及自籌部分資金出資7350萬美元,在美國設立二級子公司。該二級子公司成立後,將作為《股權購買和增資協議》的買方和增資方,取得Red Realty LLC51%的股權和對應的各項股東權利和權益。公司董事會授權經營層負責在美國設立二級子公司的具體事宜。
福安天衡(美國)有限公司(暫定名,以最終註冊為準)經營範圍:投資、技術引進與交流,技術諮詢、技術服務、貿易,與主營業務有關的境外業務拓展、境外技術合作及相關行業項目投資。(具體經營範圍最終以相關注冊登記機關核准為準)
此次擬在美國設立二級子公司主要為推進與Red Realty LLC《股權購買和增資協議》的實施,同時進一步開拓國際業務。
公司擬在美國設立二級子公司,可以加快推進《股權購買和增資協議》的實施,開拓公司國際業務。此次對外投資短期內不會對公司財務狀況和經營成果產生重大影響。該項對外投資符合公司的發展戰略,有利於公司的長遠發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.